Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Value of Serum Aluminium Monitoring in Dialysis Patients: A Multicentre Study

Identifieur interne : 002728 ( Main/Exploration ); précédent : 002727; suivant : 002729

Value of Serum Aluminium Monitoring in Dialysis Patients: A Multicentre Study

Auteurs : P. C. D'Haese [Pays-Bas] ; J. P. Clement [Pays-Bas] ; M. M. Elseviers [Pays-Bas] ; L. V. Lamberts [Pays-Bas] ; F. L. Van De Vyver [Pays-Bas] ; W. J. Visser [Pays-Bas] ; M. E. De Broe [Pays-Bas]

Source :

RBID : ISTEX:A8C5BE8FECEB1214F7BA2DD09B8ADE854C49FD13

Abstract

The clinical relevance of regular serum aluminium monitoring in dialysis patients was investigated in a multicentre study by 6-monthly determination of the serum aluminium during 4 consecutive years. In a group totalling 1193 patients, a striking decrease of mean serum aluminium was observed the last 2 years of the study. This phenomenon was accompanied by a substantial reduction of the prescribed dose of aluminium hydroxide (Al(OH)3) and its partial replacement by calcium carbonate (CaCO3) and/or magnesium hydroxide (Mg(OH)2). Under this policy serum phosphate control remained satisfactory. In all the centres, water treatment was found to be adequate, yielding dialysate aluminium around 2 ug/1. Dialysis patients with clinically overt liver disease showed a significantly greater median serum aluminium concentration than that observed in a control dialysis population. Compared to, the latter group, the median serum aluminium concentration of dialysis patients with diabetes mellitus did not differ significantly. Results further indicated that patients with biopsyproven osteomalacia presented a significantly greater median serum aluminium compared to that of patients without osteomalacia. We demonstrated that a serum aluminium of 60 μg/l provides a relatively sensitive (82%) and specific (86%) index for the detection of aluminiumrelated bone disease (ARBD). Provided the aluminium determinations are performed by a qualified laboratory, serum monitoring in dialysis patients (a) allows the safer use of aluminium-containing phosphate binders, and (b) is of value in the diagnosis of overload/toxicity.

Url:
DOI: 10.1093/ndt/5.1.45


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Value of Serum Aluminium Monitoring in Dialysis Patients: A Multicentre Study</title>
<author>
<name sortKey="D Haese, P C" sort="D Haese, P C" uniqKey="D Haese P" first="P. C." last="D'Haese">P. C. D'Haese</name>
</author>
<author>
<name sortKey="Clement, J P" sort="Clement, J P" uniqKey="Clement J" first="J. P." last="Clement">J. P. Clement</name>
</author>
<author>
<name sortKey="Elseviers, M M" sort="Elseviers, M M" uniqKey="Elseviers M" first="M. M." last="Elseviers">M. M. Elseviers</name>
</author>
<author>
<name sortKey="Lamberts, L V" sort="Lamberts, L V" uniqKey="Lamberts L" first="L. V." last="Lamberts">L. V. Lamberts</name>
</author>
<author>
<name sortKey="Van De Vyver, F L" sort="Van De Vyver, F L" uniqKey="Van De Vyver F" first="F. L." last="Van De Vyver">F. L. Van De Vyver</name>
</author>
<author>
<name sortKey="Visser, W J" sort="Visser, W J" uniqKey="Visser W" first="W. J." last="Visser">W. J. Visser</name>
</author>
<author>
<name sortKey="De Broe, M E" sort="De Broe, M E" uniqKey="De Broe M" first="M. E." last="De Broe">M. E. De Broe</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A8C5BE8FECEB1214F7BA2DD09B8ADE854C49FD13</idno>
<date when="1990" year="1990">1990</date>
<idno type="doi">10.1093/ndt/5.1.45</idno>
<idno type="url">https://api.istex.fr/document/A8C5BE8FECEB1214F7BA2DD09B8ADE854C49FD13/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">002214</idno>
<idno type="wicri:Area/Main/Curation">001F03</idno>
<idno type="wicri:Area/Main/Exploration">002728</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Value of Serum Aluminium Monitoring in Dialysis Patients: A Multicentre Study</title>
<author>
<name sortKey="D Haese, P C" sort="D Haese, P C" uniqKey="D Haese P" first="P. C." last="D'Haese">P. C. D'Haese</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>University of Antwerp, Department of Nephrology-Hypertension, Antwerp, Belgium, Utrecht</wicri:regionArea>
<placeName>
<settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
<orgName type="university">Université d'Anvers</orgName>
</affiliation>
</author>
<author>
<name sortKey="Clement, J P" sort="Clement, J P" uniqKey="Clement J" first="J. P." last="Clement">J. P. Clement</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>University of Antwerp, Department of Nephrology-Hypertension, Antwerp, Belgium, Utrecht</wicri:regionArea>
<placeName>
<settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
<orgName type="university">Université d'Anvers</orgName>
</affiliation>
</author>
<author>
<name sortKey="Elseviers, M M" sort="Elseviers, M M" uniqKey="Elseviers M" first="M. M." last="Elseviers">M. M. Elseviers</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>University of Antwerp, Department of Nephrology-Hypertension, Antwerp, Belgium, Utrecht</wicri:regionArea>
<placeName>
<settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
<orgName type="university">Université d'Anvers</orgName>
</affiliation>
</author>
<author>
<name sortKey="Lamberts, L V" sort="Lamberts, L V" uniqKey="Lamberts L" first="L. V." last="Lamberts">L. V. Lamberts</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>University of Antwerp, Department of Nephrology-Hypertension, Antwerp, Belgium, Utrecht</wicri:regionArea>
<placeName>
<settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
<orgName type="university">Université d'Anvers</orgName>
</affiliation>
</author>
<author>
<name sortKey="Van De Vyver, F L" sort="Van De Vyver, F L" uniqKey="Van De Vyver F" first="F. L." last="Van De Vyver">F. L. Van De Vyver</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>University of Antwerp, Department of Nephrology-Hypertension, Antwerp, Belgium, Utrecht</wicri:regionArea>
<placeName>
<settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
<orgName type="university">Université d'Anvers</orgName>
</affiliation>
</author>
<author>
<name sortKey="Visser, W J" sort="Visser, W J" uniqKey="Visser W" first="W. J." last="Visser">W. J. Visser</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>University Hospital of Utrecht, Clinical Research Group for Bone Metabolism Utrecht</wicri:regionArea>
<wicri:noRegion>Clinical Research Group for Bone Metabolism Utrecht</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="De Broe, M E" sort="De Broe, M E" uniqKey="De Broe M" first="M. E." last="De Broe">M. E. De Broe</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>University of Antwerp, Department of Nephrology-Hypertension, Antwerp, Belgium, Utrecht</wicri:regionArea>
<placeName>
<settlement type="city">Utrecht</settlement>
<region nuts="2" type="province">Utrecht (province)</region>
</placeName>
<orgName type="university">Université d'Anvers</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Nephrology Dialysis Transplantation</title>
<idno type="ISSN">0931-0509</idno>
<idno type="eISSN">1460-2385</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date type="published" when="1990">1990</date>
<biblScope unit="volume">5</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="45">45</biblScope>
<biblScope unit="page" to="53">53</biblScope>
</imprint>
<idno type="ISSN">0931-0509</idno>
</series>
<idno type="istex">A8C5BE8FECEB1214F7BA2DD09B8ADE854C49FD13</idno>
<idno type="DOI">10.1093/ndt/5.1.45</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0931-0509</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">The clinical relevance of regular serum aluminium monitoring in dialysis patients was investigated in a multicentre study by 6-monthly determination of the serum aluminium during 4 consecutive years. In a group totalling 1193 patients, a striking decrease of mean serum aluminium was observed the last 2 years of the study. This phenomenon was accompanied by a substantial reduction of the prescribed dose of aluminium hydroxide (Al(OH)3) and its partial replacement by calcium carbonate (CaCO3) and/or magnesium hydroxide (Mg(OH)2). Under this policy serum phosphate control remained satisfactory. In all the centres, water treatment was found to be adequate, yielding dialysate aluminium around 2 ug/1. Dialysis patients with clinically overt liver disease showed a significantly greater median serum aluminium concentration than that observed in a control dialysis population. Compared to, the latter group, the median serum aluminium concentration of dialysis patients with diabetes mellitus did not differ significantly. Results further indicated that patients with biopsyproven osteomalacia presented a significantly greater median serum aluminium compared to that of patients without osteomalacia. We demonstrated that a serum aluminium of 60 μg/l provides a relatively sensitive (82%) and specific (86%) index for the detection of aluminiumrelated bone disease (ARBD). Provided the aluminium determinations are performed by a qualified laboratory, serum monitoring in dialysis patients (a) allows the safer use of aluminium-containing phosphate binders, and (b) is of value in the diagnosis of overload/toxicity.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Pays-Bas</li>
</country>
<region>
<li>Utrecht (province)</li>
</region>
<settlement>
<li>Utrecht</li>
</settlement>
<orgName>
<li>Université d'Anvers</li>
</orgName>
</list>
<tree>
<country name="Pays-Bas">
<region name="Utrecht (province)">
<name sortKey="D Haese, P C" sort="D Haese, P C" uniqKey="D Haese P" first="P. C." last="D'Haese">P. C. D'Haese</name>
</region>
<name sortKey="Clement, J P" sort="Clement, J P" uniqKey="Clement J" first="J. P." last="Clement">J. P. Clement</name>
<name sortKey="De Broe, M E" sort="De Broe, M E" uniqKey="De Broe M" first="M. E." last="De Broe">M. E. De Broe</name>
<name sortKey="Elseviers, M M" sort="Elseviers, M M" uniqKey="Elseviers M" first="M. M." last="Elseviers">M. M. Elseviers</name>
<name sortKey="Lamberts, L V" sort="Lamberts, L V" uniqKey="Lamberts L" first="L. V." last="Lamberts">L. V. Lamberts</name>
<name sortKey="Van De Vyver, F L" sort="Van De Vyver, F L" uniqKey="Van De Vyver F" first="F. L." last="Van De Vyver">F. L. Van De Vyver</name>
<name sortKey="Visser, W J" sort="Visser, W J" uniqKey="Visser W" first="W. J." last="Visser">W. J. Visser</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002728 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002728 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:A8C5BE8FECEB1214F7BA2DD09B8ADE854C49FD13
   |texte=   Value of Serum Aluminium Monitoring in Dialysis Patients: A Multicentre Study
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024